Senta Georgia, PhD, is creating new insulin-producing cells using
CRISPR gene-editing technology in her work to cure genetic forms of diabetes.
Professor Ann Simpson, UTS School of Life Sciences and Centre for Health Technologies, is a leading Australian diabetes researcher who has developed an artificial insulin producing cell to treat Type 1 diabetes, an autoimmune disease that destroys the insulin-producing cells in the pancreas. Together with industry partner Pharmocyte Biotech Ann’s research aims to develop translational biotherapies that can be tailored to individual patients at the bedside.
Video Rating: / 5